Back to results
US 2020/0392159 A1Published application
Novel rapamycin derivatives
AssigneeNovartis AG
InventorsSimone BONAZZI, Michael CONNOLLY, David Jonathan GLASS, Manuel MIHALIC, Andrew William PATTERSON, Silvio ROGGO, Tea SHAVLAKADZE
Life of this patent
Estimating the term…
Abstract
The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.
Claims28
A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein
- R1 is selected from the group consisting of hydroxy,
- and
- R2 is selected from the group consisting of
- wherein
- m is 0, 1, 2 or 3;
- n is 1, 2 or 3;
- o is 1, 2, 3, 4, 5 or 6;
- p is 1, 2, 3, 4 or 5
- q is 1, 2, 3, 4 or 5 wherein the sum of p and q is 2, 3, 4, 5 or 6;
- r is 2, 3 or 4;
- s is 2, 3 or 4 wherein the sum of r and s is 4, 5 or 6;
- X is O, S, NR6 or SO2;
- R3 is hydrogen, C1-6alkyl, hydroxyC1-6alkyl, C3-6cycloalkylC0-6alkyl or phenylC0-6alkyl;
- R4 is hydrogen;
- R5 is hydrogen, hydroxy or cyano;
- or R4 and R5 together form ═O;
- and
- R6 is hydrogen, C1-6alkyl, C3-6cycloalkylC0-6alkyl, phenylC0-6alkyl, C1-6alkyl-CO—, C3-8cycloalkylC0-6alkyl-CO—, C1-6alkyl-SO2— or C3-8cycloalkylC0-6alkyl-SO2—.
15 more elements
Dependencies are inferred from the claim text.